Cost-minimizing alternative dosage regimens of imipenem/cilastatin/relebactam for patients with renal impairment: a pharmacokinetic/pharmacodynamic simulation study

European Journal of Clinical Pharmacology 2026

View at publisher

Authors: Xiaoping Shi, Donghui Lao, Q Y Xu, Xiaoyu Li, Bijue Liu, Qingfeng He, Xiao Zhu, Qianzhou Lv

DOI: 10.1007/s00228-025-03944-1

Cited by: 0

References: 26

Fields of Study & Subjects

Antibiotics Pharmacokinetics and Efficacy Acute Kidney Injury Research Potassium and Related Disorders

References 26